These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 36195623)
1. Treatment outcome and prognostic analysis of advanced large cell neuroendocrine carcinoma of the lung. Xia L; Wang L; Zhou Z; Han S Sci Rep; 2022 Oct; 12(1):16562. PubMed ID: 36195623 [TBL] [Abstract][Full Text] [Related]
2. Prognostic nomogram predicts overall survival in pulmonary large cell neuroendocrine carcinoma. He Y; Liu H; Wang S; Chen Y PLoS One; 2019; 14(9):e0223275. PubMed ID: 31560723 [TBL] [Abstract][Full Text] [Related]
3. Risk factors, survival analysis, and nomograms for distant metastasis in patients with primary pulmonary large cell neuroendocrine carcinoma: A population-based study. Song Z; Zou L Front Endocrinol (Lausanne); 2022; 13():973091. PubMed ID: 36329892 [TBL] [Abstract][Full Text] [Related]
4. Establishment and Validation of Prognostic Nomograms for Patients with Metastatic Pulmonary Large Cell Neuroendocrine Carcinoma. Chen X; Lai X; Huang Y; Deng C Cancer Control; 2024; 31():10732748241274195. PubMed ID: 39134429 [TBL] [Abstract][Full Text] [Related]
5. [Development and Validation of A Prognostic Nomogram to Guide Decision-making in Lung Large Cell Neuroendocrine Carcinoma]. Chen S; Li S; Wang Z; Zhang W; Zhou L; Jiao W Zhongguo Fei Ai Za Zhi; 2023 Jul; 26(7):487-496. PubMed ID: 37653012 [TBL] [Abstract][Full Text] [Related]
6. Incidence, survival comparison, and novel prognostic evaluation approaches for stage iii-iv pulmonary large cell neuroendocrine carcinoma and small cell lung cancer. Huang L; Feng Y; Xie T; Zhu H; Tang L; Shi Y BMC Cancer; 2023 Apr; 23(1):312. PubMed ID: 37020179 [TBL] [Abstract][Full Text] [Related]
7. Early death incidence and prediction in stage IV large cell neuroendocrine carcinoma of the lung. Xing H; Wu C; Zhang D; Zhang X Medicine (Baltimore); 2024 Sep; 103(37):e39294. PubMed ID: 39287289 [TBL] [Abstract][Full Text] [Related]
8. Risk factors and prognostic factors for pulmonary large cell neuroendocrine carcinoma with brain metastasis. Chen X; Huang Y; Chen F; She H; Chen X Cancer Med; 2023 Feb; 12(4):4087-4099. PubMed ID: 36125491 [TBL] [Abstract][Full Text] [Related]
9. Prognostic Nomogram for Overall Survival in Small Cell Lung Cancer Patients Treated with Chemotherapy: A SEER-Based Retrospective Cohort Study. Liang M; Chen M; Singh S; Singh S Adv Ther; 2022 Jan; 39(1):346-359. PubMed ID: 34729705 [TBL] [Abstract][Full Text] [Related]
10. Clinical response of large cell neuroendocrine carcinoma of the lung to perioperative adjuvant chemotherapy. Saji H; Tsuboi M; Matsubayashi J; Miyajima K; Shimada Y; Imai K; Kato Y; Usuda J; Kajiwara N; Uchida O; Ohira T; Hirano T; Mukai K; Kato H; Ikeda N Anticancer Drugs; 2010 Jan; 21(1):89-93. PubMed ID: 19770636 [TBL] [Abstract][Full Text] [Related]
11. Nomogram predicting overall survival of rectal squamous cell carcinomas patients based on the SEER database: A population-based STROBE cohort study. Diao JD; Wu CJ; Cui HX; Bu MW; Yue D; Wang X; Liu YL; Yang YJ Medicine (Baltimore); 2019 Nov; 98(46):e17916. PubMed ID: 31725640 [TBL] [Abstract][Full Text] [Related]
12. Development and validation of nomograms for predicting survival of elderly patients with stage I small-cell lung cancer. Yang Y; Sun S; Wang Y; Xiong F; Xiao Y; Huang J Bosn J Basic Med Sci; 2021 Oct; 21(5):632-641. PubMed ID: 33577444 [TBL] [Abstract][Full Text] [Related]
13. Survival Nomogram for Stage IB Non-Small-Cell Lung Cancer Patients, Based on the SEER Database and an External Validation Cohort. Zuo Z; Zhang G; Song P; Yang J; Li S; Zhong Z; Tan Q; Wang L; Xue Q; Gao S; Sun N; He J Ann Surg Oncol; 2021 Jul; 28(7):3941-3950. PubMed ID: 33249521 [TBL] [Abstract][Full Text] [Related]
14. A prognostic model of patients with ovarian mucinous adenocarcinoma: a population-based analysis. Yang L; Yu J; Zhang S; Shan Y; Li Y; Xu L; Zhang J; Zhang J J Ovarian Res; 2022 Feb; 15(1):26. PubMed ID: 35168642 [TBL] [Abstract][Full Text] [Related]
15. Prognostic Nomograms for Primary High-Grade Glioma Patients in Adult: A Retrospective Study Based on the SEER Database. Yang Y; Yao M; Long S; Xu C; Li L; Li Y; Li G Biomed Res Int; 2020; 2020():1346340. PubMed ID: 32775408 [TBL] [Abstract][Full Text] [Related]
16. Development and validation of a nomogram for predicting the overall survival of patients with lung large cell neuroendocrine carcinoma. Xi J; Zhao M; Zheng Y; Liang J; Hu Z; Huang Y; Yang Y; Zhan C; Jiang W; Lu T; Guo W; Wang Q Transl Cancer Res; 2020 Aug; 9(8):4943-4957. PubMed ID: 35117856 [TBL] [Abstract][Full Text] [Related]
17. Development and validation of a nomogram to predict the prognosis of patients with gastric cardia cancer. Shi X; Xu L; Ma B; Wang S Sci Rep; 2020 Aug; 10(1):14143. PubMed ID: 32839498 [TBL] [Abstract][Full Text] [Related]
18. A nomogram for predicting survival in patients with advanced (stage III/IV) pancreatic body tail cancer: a SEER-based study. Shi H; Chen Z; Dong S; He R; Du Y; Qin Z; Zhou W BMC Gastroenterol; 2022 Jun; 22(1):279. PubMed ID: 35658912 [TBL] [Abstract][Full Text] [Related]
19. Lung Large Cell Neuroendocrine Carcinoma: A Population-Based Retrospective Cohort Study. Mu X; Pu D; Zhu Y; Zhou Y; Wu Q; Liu Q; Yin L; Li Y J Clin Med; 2023 Jun; 12(12):. PubMed ID: 37373819 [TBL] [Abstract][Full Text] [Related]
20. Development and validation of a SEER-based prognostic nomogram for cervical cancer patients below the age of 45 years. Liu Q; Li W; Xie M; Yang M; Xu M; Yang L; Sheng B; Peng Y; Gao L Bosn J Basic Med Sci; 2021 Oct; 21(5):620-631. PubMed ID: 33485294 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]